Cohen Chad M 4
4 · Adaptive Biotechnologies Corp · Filed Dec 23, 2021
Insider Transaction Report
Form 4
Cohen Chad M
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2021-12-22$7.27/sh+10,000$72,700→ 31,604 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-12-22−10,000→ 80,000 totalExercise: $7.27Exp: 2029-02-07→ Common Stock (10,000 underlying) - Sale
Common Stock
2021-12-22$30.00/sh−10,000$300,000→ 21,604 total
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2020.
- [F2]The options vested with respect to 1/4 of such shares on January 1, 2020, with 1/48 of such shares vesting thereafter at the end of each full month of continuous service until fully vested.